ad image

Biologics – Large Molecules

1 / 1
Biosimilars Through the Years: Transforming Access and Cost in Biologics
Biosimilars

Biosimilars Through the Years: Transforming Access and Cost in Biologics

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-01Mar 02, 2025
Personalized Medicine and the CDMO: Adapting to a New Era of Healthcare
Personalized

Personalized Medicine and the CDMO: Adapting to a New Era of Healthcare

Ola Tuvesson; Isa Lindgren, Ph.D.

NorthX Biologics

PAO-01-25-CL-09Feb 14, 2025
AI Implementation to Enhance Quality
AI

AI Implementation to Enhance Quality

Seongil Cho; Hyeokgeon Kwon; Kisung Shim

Samsung Biologics

PAO-12-24-CL-5Dec 13, 2024
1 / 1